LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 14 filers reported holding LAVA THERAPEUTICS NV in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,373 | -41.5% | 64,009 | -20.4% | 0.00% | – |
| Q2 2023 | $163,159 | -8.8% | 80,374 | +105.2% | 0.00% | – |
| Q3 2022 | $179,000 | -35.1% | 39,163 | -59.4% | 0.00% | – |
| Q2 2022 | $276,000 | -58.4% | 96,405 | -36.0% | 0.00% | – |
| Q1 2022 | $663,000 | +192.1% | 150,630 | +265.3% | 0.00% | – |
| Q4 2021 | $227,000 | -46.6% | 41,238 | -42.6% | 0.00% | – |
| Q3 2021 | $425,000 | -71.9% | 71,833 | -48.3% | 0.00% | -100.0% |
| Q2 2021 | $1,510,000 | -56.1% | 138,831 | -38.6% | 0.00% | -50.0% |
| Q1 2021 | $3,436,000 | – | 226,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |